Results 161 to 170 of about 965,123 (374)

Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice? [PDF]

, 2020
John Munkhaugen, Elise Sverre, Kari Peersen, Oscar Kristiansen, Erik Gjertsen, Lars Gullestad, Jan Erik Otterstad   +6 more
openalex   +1 more source

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles

Annals of Neurology, EarlyView.
Objective Identifying modifiable factors influencing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) risk is important for prevention. Blood biomarkers, particularly cholesterol, have been associated with neurodegenerative risk, but findings in ALS are inconsistent, and data on FTD are limited.
Christos V. Chalitsios, Jiali Gao, Carol A.C. Coupland, Julia Hippisley Cox, Martin R. Turner, Alexander G. Thompson   +5 more
wiley   +1 more source

Correlation of LDL Cholesterol Calculated by Friedewald’s, Puavilai’s, Vujovic’s, de Cordova’s and Martin’s Formulae with Directly Measured LDL Cholesterol: A Cross-sectional Study

, 2023
Sudha Ambiger, Fatima Farheen, Kamarudin Jaalam, Javali Shivalingappa   +3 more
openalex   +1 more source

Electronic Health Records to Test Multimorbidity Influences to Plasma Biomarker Interpretation for Alzheimer's Disease

Annals of Neurology, EarlyView.
Objective Plasma biomarkers of Alzheimer's disease (AD) pathology are frequently tested in specialized research settings, which limits the generalizability of findings. Using electronic health records and banked plasma, we evaluated plasma biomarkers—phosphorylated tau 217 (p‐tau217), β‐amyloid 1–42/1–40 (Aβ42/Aβ40) and p‐tau217/Aβ42—in a real‐world ...
Katheryn A.Q. Cousins, Rory Boyle, Colleen Morse, Anurag Verma, Christopher A. Brown, Kyra S. O'Brien, Marina Serper, Nadia Dehghani, Penn Medicine BioBank, Corey T. McMillan, Edward B. Lee, Leslie M. Shaw, David A. Wolk   +12 more
wiley   +1 more source

Surface‐Coated Inorganic Nanomaterials for Drug Delivery: Chemical Design, Biomedical Applications, and Mechanistic Insights

Advanced NanoBiomed Research, EarlyView.
This review explores how surface‐coated inorganic nanomaterials are chemically engineered for advanced drug delivery. It highlights design principles, coating strategies, and biomedical applications, emphasizing how surface chemistry governs biocompatibility, targeting, and controlled release.
Hossein Daneshgar, Sepideh Ahmadi, Nikzad Abbariki, Navid Rabiee, Sidi A. Bencherif   +4 more
wiley   +1 more source

Effects of psyllium on LDL-cholesterol concentrations in Brazilian children and adolescents: a randomised, placebo-controlled, parallel clinical trial [PDF]

, 2014
Simone Augusta Ribas, Diana Barbosa Cunha, Rosely Sichieri, Luiz Carlos Santana da Silva   +3 more
openalex   +1 more source

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

New England Journal of Medicine, 2017
K. Ray, U. Landmesser, Lawrence A Leiter, D. Kallend, R. Dufour, M. Karakas, T. Hall, R. Troquay, T. Turner, F. Visseren, P. Wijngaard, R. Wright, J. Kastelein   +12 more
semanticscholar   +1 more source

Fibers as Oleogelators: Innovations, Applications, and Future Prospects in Structured Lipid Systems

Journal of the American Oil Chemists' Society, EarlyView.
Schematic overview of fiber‐based oleogelation mechanisms, processing routes, and food applications highlighting particulate/capillary structuring, polymer entanglement, and emulsion‐templated approaches. ABSTRACT Oleogels, structured oil systems created with low levels of gelators‐enables solid fat functionality while preserving the underlying liquid ...
P. Abdul Wahid, Rajni Chopra, Nitin Kumar, Monika Chand, Aishwarya Dhiman, Rajat Singh   +5 more
wiley   +1 more source

THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERLIPIDEMIAS (POSCH) AND THE LIPID REGULATORY HYPOTHESIS

European Medical Journal Cardiology, 2015
Background: The Lipid Regulatory Hypothesis (LRH) states that the best way to regress atherosclerotic plaque is to simultaneously decrease the cholesterol being transported into the arterial wall by low-density lipoprotein (LDL) and increase the ...
William E. Feeman, Jr, Stanley E. Williams, Henry Buchwald   +2 more
doaj  

Sequestration of acetylated LDL and cholesterol crystals by human monocyte-derived macrophages. [PDF]

, 1995
Howard S. Kruth, S I Skarlatos, Katie J Lilly, Joan Chang, Ina Ifrim   +4 more
openalex   +1 more source